Download PDF

Register to download the report. Already a member?

 
 
Sign Up

Or

60275 1492790397HCLSReviewGreeceApril2017.pdf
Energy Boardroom

Bayer targets €500m after EU OK for Adempas

01.04.2014 / Scripintelligence

This is the first drug to be approved in the EU for chronic thromboembolic pulmonary hypertension (CTEPH), a rare disease estimated to affect around 8-40 people per million globally. The patient population is similar to Adempas's other newly approved…

LATEST ISSUE

DOWNLOAD

X
Download PDF

First Name:

Last Name:

Company:

Position:

Country:

Email: